China Insulin Delivery Market Outlook to 2022

GlobalData
42 Pages - GLDATA57686
$4,995.00

Summary

GlobalData’s new report, "China Insulin Delivery Market Outlook to 2022", provides key market data on the China Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Insulin Delivery market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the China Insulin Delivery market.
- Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Medtronic plc
Eli Lilly and Company
Becton Dickinson and Co
F. Hoffmann-La Roche Ltd
Novo Nordisk A/S
Sanofi
Owen Mumford Ltd
B. Braun Melsungen AG

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Insulin Delivery Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Insulin Delivery Market, China 7
3.1 Insulin Delivery Market, China, Revenue ($m), 2008-2015 7
3.2 Insulin Delivery Market, China, Revenue ($m), 2015-2022 9
3.2.1 Insulin Pens Market, China, Revenue ($m), by Segment, 2008-2015 11
3.2.2 Insulin Pumps Market, China, Revenue ($m), by Segment, 2008-2015 13
3.2.3 Insulin Pens Market, China, Revenue ($m), by Segment, 2015-2022 14
3.2.4 Insulin Pumps Market, China, Revenue ($m), by Segment, 2015-2022 16
3.3 Insulin Delivery Market, China, Volume (Units), 2008-2015 17
3.4 Insulin Delivery Market, China, Volume (Units), 2015-2022 19
3.4.1 Insulin Pens Market, China, Volume (Units), by Segment, 2008-2015 21
3.4.2 Insulin Pumps Market, China, Volume (Units), by Segment, 2008-2015 23
3.4.3 Insulin Pens Market, China, Volume (Units), by Segment, 2015-2022 24
3.4.4 Insulin Pumps Market, China, Volume (Units), by Segment, 2015-2022 26
3.5 Insulin Delivery Market, China, Average Price ($), 2008-2022 27
3.6 Insulin Delivery Market, China, Distribution Share by Revenue ($m), 2014-2015 29
3.7 Insulin Delivery Market, China, Company Share by Revenue ($m), 2015 30
4 Overview of Key Companies in China, Insulin Delivery Market 32
4.1 Medtronic plc 32
4.1.1 Company Overview 32
4.2 Eli Lilly and Company 32
4.2.1 Company Overview 32
4.3 Becton Dickinson and Co 32
4.3.1 Company Overview 32
4.4 F. Hoffmann-La Roche Ltd 33
4.4.1 Company Overview 33
4.5 Novo Nordisk A/S 33
4.5.1 Company Overview 33
4.6 Sanofi 33
4.6.1 Company Overview 33
4.7 Owen Mumford Ltd 34
4.7.1 Company Overview 34
4.8 B. Braun Melsungen AG 34
4.8.1 Company Overview 34
5 Insulin Delivery Market Pipeline Products 35
6 Financial Deals Landscape 36
6.1 Partnerships 36
6.1.1 Harmony Biopharm Forms Joint Venture with Tonghua Dongbao Pharma and Shanghai Dongbao Biological Pharma 36
6.1.2 Metabolon Enters into Licensing Agreement with Synlab 37
7 Appendix 38
7.1 Research Methodology 39
7.1.1 Coverage 39
7.1.2 Secondary Research 39
7.1.3 Primary Research 40
7.1.4 Company Share Analysis 40
7.1.5 Distribution Share Analysis 40
7.1.6 Benchmarking 41
7.2 GlobalData Consulting 41
7.3 Contact Us 41
7.4 Disclaimer 42

1.1 List of Tables
Table 1: Insulin Delivery Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 8
Table 2: Insulin Delivery Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Table 3: Insulin Pens Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 12
Table 4: Insulin Pumps Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 13
Table 5: Insulin Pens Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 15
Table 6: Insulin Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Table 7: Insulin Delivery Market, China, Volume (Units), Historic, 2008-2015 18
Table 8: Insulin Delivery Market, China, Volume (Units), Forecast, 2015-2022 20
Table 9: Insulin Pens Market, China, Volume (Units), Historic, 2008-2015 22
Table 10: Insulin Pumps Market, China, Volume (Units), Historic, 2008-2015 23
Table 11: Insulin Pens Market, China, Volume (Units), Forecast, 2015-2022 25
Table 12: Insulin Pumps Market, China, Volume (Units), Forecast, 2015-2022 26
Table 13: Insulin Delivery Market, China, Average Price ($) Historic, 2008-2022 27
Table 14: Insulin Delivery Market, China, Average Price ($), Forecast, 2015-2022 28
Table 15: Insulin Delivery Market, China, Distribution Share by Revenue ($m), USD Constant, 2014-2015 29
Table 16: Insulin Delivery Market, China, Company Share by Revenue ($m), USD Constant, 2015 31
Table 17: Insulin Delivery Market Pipeline Products 35
Table 18: Harmony Biopharm Forms Joint Venture with Tonghua Dongbao Pharma and Shanghai Dongbao Biological Pharma 36
Table 19: Metabolon Enters into Licensing Agreement with Synlab 37

1.2 List of Figures
Figure 1: Insulin Delivery Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 7
Figure 2: Insulin Delivery Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 9
Figure 3: Insulin Pens Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 11
Figure 4: Insulin Pumps Market, China, Revenue ($m), USD Constant, Historic, 2008-2015 13
Figure 5: Insulin Pens Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 14
Figure 6: Insulin Pumps Market, China, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Figure 7: Insulin Delivery Market, China, Volume (Units), Historic, 2008-2015 17
Figure 8: Insulin Delivery Market, China, Volume (Units), Forecast, 2015-2022 19
Figure 9: Insulin Pens Market, China, Volume (Units), Historic, 2008-2015 21
Figure 10: Insulin Pumps Market, China, Volume (Units), Historic, 2008-2015 23
Figure 11: Insulin Pens Market, China, Volume (Units), Forecast, 2015-2022 24
Figure 12: Insulin Pumps Market, China, Volume (Units), Forecast, 2015-2022 26
Figure 13: Insulin Delivery Market, China, Company Share (%) 2015 30

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports